Nanogen Issued Patent for Addressable Biologic Electrode Arrays - New Technology

Nanogen, Inc announced today that it was issued U.S. Patent No. 6,682,936, "Addressable Biologic Electrode Array," by the U.S. Patent and Trademark Office. The '936 patent relates to electrode-based array devices and methods of operation in which individual electrodes contained within the array can be selectively addressed or manipulated. The technology enables high-density electrode arrays to be produced and has applications for the hybridization as well as combinatorial synthesis and self-assembly of biological molecules, such as nucleic acids and peptides. The technology also enables the production of smaller and more compact arrays, while at the same time minimizing the utilization of off-chip control circuitry, even for large numbers of electrodes.

The technology described in the patent relates to Nanogen's advanced chip designs, which can be used for biological applications and also for nanofabrication applications, such as those described in several other Nanogen patents including the Company's recently issued U.S. Patent No. 6,652,808. With the addition of the '936 patent, Nanogen now has 57 issued patents in the United States.

"Customers using biomedical diagnostic applications -- and ultimately the patients they serve -- will require increasingly sophisticated capabilities at reasonable cost," said Howard Birndorf, Nanogen chairman and chief executive officer. "Application of the technology described in this patent allows for continually increasing array densities and capabilities, which simultaneously would reduce both array cost and instrument size."

"One of the challenges in producing biologic arrays of increasing density is the integration of electronic control circuitry with each electrode on the array. The new patent describes a semiconductor-based switching technology that helps solve these scaling issues," said Dr. Michael J. Heller, co-founder of Nanogen, and currently a professor in the Departments of Bioengineering and Electrical and Computer Engineering at the University of California, San Diego.

Posted 28th January 2004

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanogen. (2013, June 11). Nanogen Issued Patent for Addressable Biologic Electrode Arrays - New Technology. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/article.aspx?ArticleID=453.

  • MLA

    Nanogen. "Nanogen Issued Patent for Addressable Biologic Electrode Arrays - New Technology". AZoNano. 21 November 2024. <https://www.azonano.com/article.aspx?ArticleID=453>.

  • Chicago

    Nanogen. "Nanogen Issued Patent for Addressable Biologic Electrode Arrays - New Technology". AZoNano. https://www.azonano.com/article.aspx?ArticleID=453. (accessed November 21, 2024).

  • Harvard

    Nanogen. 2013. Nanogen Issued Patent for Addressable Biologic Electrode Arrays - New Technology. AZoNano, viewed 21 November 2024, https://www.azonano.com/article.aspx?ArticleID=453.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.